Research on the role of serotonin (+hydroxytryptamine, in the function of the enteric nervous system has been impeded by the lack of specific inhibitors of the enteric neural actions of 5-HT. Saturable, reversible, high affinity enteric binding sites for 3H-5-HT have recently been characterized and radioautographically located. Affinity for the 3H-5-HT binding site requires an indole ring substituted with a free hydroxyl group. These 3H-5-HT binding sites have been proposed to be enteric neural 5-HT receptors.
in the function of the enteric nervous system has been impeded by the lack of specific inhibitors of the enteric neural actions of 5-HT. Saturable, reversible, high affinity enteric binding sites for 3H-5-HT have recently been characterized and radioautographically located. Affinity for the 3H-5-HT binding site requires an indole ring substituted with a free hydroxyl group. These 3H-5-HT binding sites have been proposed to be enteric neural 5-HT receptors.
This hypothesis was tested in the current study by comparing the ability of compounds to inhibit the binding of 3H-5-HT with their electrophysiologically determined actions on myenteric neurons. 5-Methoxytryptamine did not inhibit the binding of 3H-5-HT to enteric membranes and neither mimicked nor antagonized the effects of 5-HT on the membrane potential of myenteric neurons. Two dipeptides of 5-hydroxytryptophan, N-acetyland N-hexanoyl-5-hydroxytryptophyl-5-hydroxytryptophan amide (5-HTP-DP and N-hex-5-HTP-DP) inhibited the binding of 3H-5-HT (K, = 0.25 PM for 5-HTP-DP and 1.19 KM for N-hex-5-HTP-DP).
5-HTP-DP applied by pressure microejection or superfusion (10 PM) antagonized the slow postsynaptic depolarization of myenteric neurons evoked by microejection of 5-HT. 5-HTP-DP also blocked the 5-HT-induced presynaptic reduction in amplitude of nicotinic fast synaptic potentials; however, 5-HTP-DP itself did not affect these responses. Moreover, 5-HTP-DP also failed to affect responses of myenteric neurons to microejected substance P, their muscarinic response to acetylcholine, or antidromic action potentials.
In contrast, both dipeptides blocked the slow synaptic potentials seen in type II/AH neurons following
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3 To whom correspondence should be addressed, at the Department of Anatomy and Cell Biology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032. stimulation of fiber tracts in interganglionic connectives. These data support the hypotheses that enteric 3H-5-HT binding sites are enteric neural 5-HT receptors, that dipeptides of 5-hydroxytryptophan are specific antagonists at these receptors, and that 5-HT is one of the mediators of slow synaptic potentials in the myenteric plexus.
Receptors for serotonin @hydroxytryptamine, 5HT) in the gut were first classified as M or D receptors by Gaddum and Picarelli (1957) . Responses to 5-HT mediated by M receptors were defined as those blocked by morphine, and D receptor-mediated responses were defined as those blocked by dibenzyline (phenoxybenzamine). These agents are not specific antagonists of 5-HT. Morphine, for example, probably blocks the contraction of the gut in response to addition of 5-HT by inhibiting the release of acetylcholine (ACh) from the final common excitatory neurons activated by 5-HT (Paton, 1957; Schaumann, 1957) . 5-HT contracts the gut through the release of ACh (Vizi and Vizi, 1978) . Nevertheless, the M receptors are probably entirely neural, whereas the D receptors for 5-HT are on the smooth muscle (Gaddum and Picarelli, 1957; Brownlee and Johnson, 1963; Gyermek, 1966; Drakontides and Gershon, 1968; Fozard and Mobarok Ali, 1978) . M receptors are thus found in myenteric and submucosal ganglia, both of which respond to 5-HT (Hirst and Silinsky, 1975; Wood and Mayer, 197913; Johnson et al., 1980b) , and on mucosal afferent nerves that initiate the peristaltic reflex (BDlbring and Crema, 1958; Bijlbring and Lin, 1958) .
Previous experiments have led to the description of high affinity, saturable, reversible binding sites for 3H-5-HT in enteric membranes (Branchek et al., 1984) . Because of the similarity between the structural requirements of analogues for affinity to the 3H-5-HT binding sites and those for pharmacological activity at M receptors, it was proposed that the 3H-5-HT binding sites were in fact M receptors for 5-HT. These sites were subsequently localized in tissue by radioautography and were found in enteric ganglia and at the mucosal-submucosal junction (possibly in mucosal nerves and submucosal ganglia) but not in smooth muscle. The tissue localization of the 3H-5-HT binding sites thus is appropriate for M and not D 5-HT receptors and supports the proposal that the high affinity binding sites for 3H-5-HT in the gut are M receptors.
The 3H-5-HT binding sites (and M receptors) are quite different from either of the main classes of 5-HT receptor known from work on the CNS. The CNS S, receptor for 5-HT has a high affinity for 3H-5-HT and also for d-lysergic acid diethylamide (d-LSD) (Bennett and Snyder, 1976; Peroutka and Snyder, 1979) . The CNS Sp receptor for 5-HT has a low affinity for 3H-5-HT but a high affinity for d-LSD and drugs such as spiroperidol and ketanserin (Peroutka and Snyder, 1979; Leysen et al., 1982) . Spiroperidol can also be used to differentiate subtypes of the S, receptor (Pedigo et al., 1981 and N-hexanoyl-5-hydroxytryptophyl-5-hydroxytryptophan amide (N-hex-5-HTP-DP).
One potential agonist, 5-methoxytryptamine (5-MEOT) was also investigated.
This compound is of interest because it has been reported to be an M receptor agonist in the gut (Fozard and Mobarok Ali, 1978) and it displays affinity for CNS S, 5-HT receptors (Nelson et al., 1981; Fuller, 1984 were changed, 10 to 140 set elapsed before the drug arrived in the organ bath where the tissue was maintained.
Solutions containing drugs were never recirculated.
When pressure microelectIon was used, all drugs--5.HT
(1 mM), ACh (10 mM), substance P (0.6 mM), 5-HTP-DP (1 to 10 mM), and N-hex+HTP-DP
(1 to 10 mM)-were applied to the neurons from fine pipettes (10 to 20 pm in diameter) by pressure with pulses of nitrogen gas (300 kg/cm'; 10 to 999 msec in duration) (Picospritzer II, General Valve Corp., Fairfield, NJ). Pipettes contained 0.01% fast green dye in Krebs solution as well as the compounds under study. The distance between the tip of the micropipette and the recording electrode was maintained between 50 and 100 pm, and the arrival of compounds at the impaled cells was visually certified.
After the first application of drugs by pressure microejection, the perfusate was never recirculated. was from Sigma Chemical Co., substance P was from Peninsula Laboratories (Belmont, CA), and tetrodotoxin was from Sankyo (Tokyo, Japan).
Drug preparaf/on. All drugs except for substance P and 5-HTP-DP and Nhex-5-HTP-DP used in the present study were dissolved with Krebs solution. Substance P was dissolved with 0.1% bovine serum albumin and Krebs solution and stored at -20°C until used. When used, substance P was diluted 10 times with Krebs solution. 5-HTP-DP and N-hex-5-HTP-DP were first dissolved with 100% ethanol or dimethylsulfoxide (DMSO) and then diluted with Krebs solution to a final concentration of 10% ethanol or 10% DMSO. Solutions containing 5-HTP-DP (1 to 10 mM) were stored in the dark at -20°C.
As controls, the effects of 0.1 to 10% ethanol and DMSO and 0.01 to 0.1% fast green solution on the electrophysiological behavior of 14 type II/AH and 4 NS myentenc neurons were examined. No actions of ethanol, DMSO, or fast green were found. 
Results

Effects
Physiological studies
Classification of myenteric neurons. The neurons of the myenteric plexus were classified physiologically into three categories (Holman et al., 1972; Nishi and North, 1973; Hirst et al., 1974; Wood, 1983) . Type I/S cells were defined as those with a high input resistance, which spiked repeatedly during the injection of a depolarizing current and which displayed anodal break excitation. Type II/AH cells were defined as those with a low input resistance and which displayed a characteristic prolonged afterhyperpolarization following an action potential. During the afterhyperpolarization the cell was refractory. These cells usually did not show anodal break excitation except when activated by application of exogenous compounds such as 5-HT or during a slow EPSP. NS cells were defined as those cells that did not spike in response to injection of depolarizing current, stimulation of interganglionic fiber tracts, or application of drugs. The sample studied included 52 type II/AH cells, 32 NS cells, and 10 type I/S cells.
The action of 5-HT on myenteric neurons. In confirmation of previous observations by Wood and Mayer (1979b) and Johnson et al. (1980b) , 5-HT applied by pressure microejection or by superfusion (at high concentration: 10 to 100 FM) was found to induce a longlasting depolarization in type II/AH neurons. After microejection of an approximately threshold pulse of 5-HT, the mean duration of the response was 29.0 f 2.6 set and the amplitude was 14.5 + 1.4 mV (N = 16). This response was associated with an increased input resistance. During the response, the afterhyperpolarization that characterizes type II/AH neurons was antagonized and, as a consequence, the cells became hyperexcitable.
This effect of 5-HT is concentration dependent (Fig. 3) and was seen in 61% of type II/ AH cells (Table I) . Other types of effect were also seen in response to application of 5-HT by microejection. The most common effect besides the slow depolarization was a rapid depolarization associated with a fall in input resistance (Fig. 4) which was observed in 55% of type II/AH cells. After microejection of an approximately threshold pulse of 5-HT, the mean duration of this response was 2.1 + 0.1 set and the amplitude was 19.6 f 2.3 mV (N = 14). This response is thus significantly shorter than that of the slow depolarization evoked by 5-HT (p < 0.001). The fast response to 5-HT was not antagonized by hexamethonium (0.1 mM), tetrodotoxin (3.1 PM), Ca"-free media (with 0.1 mM EGTA), high Mg'+ (12.5 mM)-containing media, or naloxone (IO FM). It was always abolished by desensitization with superfused 5-HT (10 PM). The fast response, therefore, appears to be a direct postsynaptic response to 5-HT. More rarely (5%), a hyperpolarization, also associated with a decrease in input resistance, was seen. The fast depolarization was usually accompanied by a burst of action potentials which in turn were followed by an afterhyperpolarizafion.
This biphasic response has been described by Johnson et al. (1980b) . The biphasic response was often, in turn, succeeded by the characteristic 5-HT-induced slow depolarization during which the afterhyperpolarization of type II/AH cells was blocked and the input resistance was increased (Figs. 4, 7, and 8) . This complex fast and slow response to 5-HT was seen in 29% of type II/AH cells (Table I) . Type I/S cells and NS cells also responded to 5-HT. The responses of these cells to 5-HT were studied much less thoroughly than those of type II/AH cells which formed the major target of this investigation; however, the types of response seen and their incidence in the cells encountered are summarized in table I.
Actions of 5-MEOT on type II/AH neurons 5-MEOT, applied to the surface of three type II/AH neurons and one type I/S neuron by pressure microejection, failed to mimic any of the actions of 5HT applied to the same neurons, even when Vol. 5, No. 7, July 1985 Increasing the duratton of the pulse used for pressure microejection of 5-HT (1 mM; arrowheads) from 50 to 300 msec increases the amplitude of the depolanzation, its duration, and the frequency of action potentials induced by 5-HT. Constant hyperpolarlzing current pulses were injected into the cell through the recording microelectrode. Note the Increase in input resistance during the depolarizing response to 5-HT. This effect was not blocked by tetrodotoxin (3.1 PM; not shown). The resting membrane potential was -71 mV.
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applied at 20 times the volume of 5-HT (Fig. 4) . When 5-HT was applied after 5-MEOT, its action was unchanged from control (Fig. 4, C to E) . In three of nine type II/AH cells, 5-MEOT applied by superfusion at high concentration (5 to IO PM) did produce a depolarization. In five of nine type II/AH cells and one of one type I/ S cell, 5MEOT superfusion (10 PM) had no effect. One type II/AH cell was hyperpolarized by 5-MEOT. However, the depolarizing effect of 5-MEOT (not illustrated) was quite different from that of 5-HT. It was a prolonged action associated with a fall, not a rise, in input resistance. When cells were depolarized by 5-MEOT, they no longer responded to 5-HT. Although 5HT can also induce a depolarization associated with a decrease in input resistance (fast depolarization; see above) this 5-HT effect is transient. It is evoked only by pulses of 5-HT and cannot be induced by superfusion; therefore, the actions of 5MEOT and 5-HT differed in means of elicitation and time course. Moreover, the fast depolarizing response to 5-HT could be elicited in cells that did not respond to superfusion with 5-MEOT (Fig. 5) . Furthermore, the fast response to 5-HT in these cells was not blocked by superfusion with 5-MEOT. In contrast, the fast depolarization induced by 5-HT, like the slow depolarization, was readily antagonized by desensitizing the preparations by superfusion with 5-HT (10 PM) itself (Fig. 5) . It seems, therefore, that 5-MEOT does not act on the same enteric neural receptors as does 5-HT.
Antagonism of the actions of 5HT on type II/AH ceils by SHTP-DP Superfusion of tissues with 1 to IO PM 5-HTP-DP reversibly antagonized the slow depolarization associated with increased input resistance induced by 5-HT (Fig. 6 ). This action of 5-HTP-DP could be overcome by increasing the duration of the pressure pulse for microejection of 5-HT (and thus the amount of 5-HT applied). Antagonism of the action of 5-HT could also be demonstrated by of 5-HTP-DP (Fig. 7) . In 40% of cells both the fast and the slow depolarization induced by 5HT were blocked by 5-HTP-DP; however, the ability of the dipeptide to block the fast depolarization was not constant (Fig. 8) . In contrast, the slow depolarization was more sensitive to antagonism by 5HTP-DP and could be blocked by the dipeptide at concentrations of drug that did not block the fast depolarization (Fig. 8) . The slow depolarization induced by 5HT was reversibly antagonized by 5-HTP-DP in 100% of trials. This antagonistic action of 5-HTP-DP against 5HT was concentration dependent and required relatively high concentrations of drug. In super-fusion experiments at least 1 PM 5HTP-DP was required and, for some cells, a concentration of IO PM 5-HTP-DP (and rarely 20 FM) was needed to block the action of microejetted 5-HT. When both compounds were given by pressure microejection, concentrations of the two compounds at the impaled cell were not known; however, 10 to 30 drops of 5-HTP-DP (10 mM) were required to antagonize the effects of 1 drop of 5-HT (1 mM) (Fig. 8) . Twenty drops of 5HTP-DP reduced the mean depolarization induced by 5-HT to 33% of the control value (p c 0.01) and the duration to 47% (p < 0.01). Thirty drops virtually abolished the response to 5-HT, reducing the mean depolarization to <lo% of control and the duration to <15% (p < 0.01).
5-HTP-DP (10 mM) applied by microejection to the surface of type II/AH neurons failed to mimic any of the agonist actions of 5-HT (1 mM) applied to the same cells. No cells displayed either a fast or a slow depolarization, a hyperpolarization, or a change in input resistance in response to microejection of 1 to 30 drops of 5-HTP-DP (10 mM). The drug thus appears only to be a 5-HT antagonist. N-hexd-HTP-DP had actions similar to those of 5-HTP-DP except that it was less potent against exogenous 5-HT and, perhaps because of its greater lipid solubility, was difficult to wash out.
Specificity of 5-HTP-DP as a 5-HT antagonist
In order to examine the specificity of 5-HTP-DP for 5-HT receptors, the ability of 5-HTP-DP to antagonize responses of type II/AH neurons to substance P and ACh was investigated. The action of substance P (Katayama and North, 1978; Katayama et al., 1979) and the muscarinic actions of ACh (Morita et al., 1982; North and Tokimasa, 1982) on these cells are similar to the slow depolarization induced by 5-HT. Both substance P and ACh, as well as 5-HT, produce a long-lasting depolarization of myenteric neurons associated with an increase in input resistance. Neither the response of type II/AH neurons to substance P (Fig. 9) nor the muscarinic response of these neurons to ACh were blocked by superfusion with as much as 10 to 20 PM 5-HTP-DP. In addition, the response elicited by pressure microejection of 1 drop of ACh was not blocked by pressure microejection of 30 drops of 5-HTP-DP (1 to 10 mM) (Fig. 10) . Nevertheless, this amount of pressure microejected 5-HTP-DP readily antagonizes responses to 1 drop of 5-HT (see Figs. 7 and 8) .
As a further test of the specificity of 5-HTP-DP, the action of the compound on fast EPSPs was determined. These were examined in type I/S cells and were elicited by stimulation of an interganglionic fiber tract. This response is known to be nicotinic (Nishi and North, 1973) and, indeed, we found the response to be abolished by hexamethonium (0.1 mM) (Fig. 11) . Testing 5-HTP-DP against the fast EPSP, therefore, evaluates the action of the compound on nicotinic receptors and also on the release of ACh. Superfusion with 5-HTP-DP (1 .O to 10 PM) did not antagonize the fast EPSP induced by fiber tract stimulation (Fig. 12) ; therefore, 5-HTP-DP does not antagonize the nicotinic actions or the release of ACh. In contrast to 5-HTP-DP, 5-HT is known to act presynaptically to reduce the release of ACh and thus diminish the amplitude of the fast EPSP (North et al., 1980) . This presynaptic effect of 5-HT, like its postsynaptic actions, was reversibly antagonized by 5-HTP-DP (Fig. 12) .
Effect of 5-HTP-DP on slow EPSPs in type II/AH neurons
Slow EPSPs can be elicited in both type I/S and type II/AH neurons (Johnson et al., 1980a) ; however, 5-HT has only been postulated to be a mediator of slow EPSPs in type II/AH cells (Wood and Mayer, 1979b) . The slow EPSP elicited in type II/AH neurons by repetitive fiber tract stimulation is mimicked by the slow depolarization induced by 5-HT (Fig. 13) . The action of 5-HTP-DP was thus tested on slow EPSPs elicited by repetitive stimulation of fiber tracts in interganglionic connectives. The slow EPSP in type II/AH neurons was found and 5-HT on a type II/AH neuron. The cell is injected with constant hyperpolarizing current pulses. Action potentials are followed by a pronounced afterhyperpolarization (AH). A, 5-MEOT (1 mM; arrowhead) applied by pressure microejection has no effect, B, Application of 5. HT (1 mM, 800 msec; arrowhead) by pressure microejection causes several action potentials and a fast (transient) depolarization associated with decreased input resistance followed by a slow depolarization. During the slow depolarization input resistance is increased, the AH is antagonized, and action potential frequency increases. C, At a slower speed 5-HT (1 mM, 800 msec; arrowhead) induces a similar response. During the initial fast depolarization evoked by 5-HT the cell fires several action potentials.
These are followed by a pronounced AH which is lost during the following phase of slow depolarization. The cell is hyperexcitable during this late portion of the response to 5-HT. D, After this response to 5-HT, 5-MEOT (1 mM, 800 msec; 20 drops between arrows) produces no effect. E, Following application of 5-MEOT the application of 5-HT evokes an effect similar to that seen before 5-MEOT. The resting membrane potential was -74 mV. a fast depolarization is evoked despite the continued superfuslon with 5MEOT. D, 5-MEOT is washed out and the preparation (arrowhead) continues to respond to 5-HT as before. E, Superfusion with 5HT (10 PM) is begun at the arrow. F, Super-fusion with 5-HT has desensitized the preparation and 5HT no longer evokes a response. The resting membrane potential of this cell was -74 mV.
to be reversibly antagonized by 5-HTP-DP or N-hexd-HTP-DP in eight of eight type II/AH cells (Figs. 14 and 15). Both blocked the slow EPSP when applied by superfusion at 1 to 10 PM or when applied by pressure microejection from pipettes containing 10 mM (Fig. 14) but not 1 mM concentrations of the peptides. The slow EPSP was also blocked in these neurons by desensitization to 5-HT (Fig. 15) . Repetitive stimulation of a fiber tract sometimes evoked a hyperpolarizing response associated with a decrease in input resistance prior to the appearance of the slow EPSP (Fig. 15) . This effect was blocked neither by N-hexd-HTP-DP nor by desensitization to 5-HT. Slmllarly, antidromic action potentials were often elicited in type II/AH neurons by fiber tract stimulation (not illustrated). These potentials were never affected by superfusion with 5-HTP-DP (10 PM).
Discussion
Three major objectives formed the core of the current study. One was to evaluate the ability of 5-MEOT to act as an agonist or antagonist at 5-HT receptors. Previous experiments on the binding of 3H-5-HT (Branchek et al., 1984; Gershon et al., 1984a, b) had led to the prediction that 5-MEOT would not act like 5-HT. A second objective was to analyze the action of two dipeptides of 5-hydroxytrptophan, 5-HTP-DP and N-hexd-HTP-DP, on the high affinity enteric binding of 3H-5-HT and on neurons of the myenteric plexus. Studies of the structural requirements for affinity at enteric 3H-5-HT binding sites (Branchek et al., 1984; Gershon et al., 1984b) and the known figure 6. Antagonism of the slow depolarizing response to 5-HT by superfusion with 5HTP-DP. This type II/AH cell was injected with constant hyperpolarizing current pulses through the recording micropipette. A, A brief 50-msec (arrow) microejection of 5-HT induces a slow depolarization. During the response there is anodal break excitation. 6, The response to 5-HT (arrow) is blocked by superfusion with 10 FM 5-HTP-DP (the response to a 1 00-msec pulse of 5-HT was reduced (not shown) but not abolished by 5-HTP-DP). C, When the dipeptide is washed out, the slow depolarizing response to 5-HT (arrow) returns. Action potentials occur during the depolarizing response and there is also anodal break excitation. The resting membrane potential was -71 mV.
5-HT
pharmacology of 5-HT M receptors (Drakontides and Gershon, 1968; Fozard and Mobarok Ali, 1978; Costa and Furness, 1979b) had led to the prediction that these compounds would be active at M receptors. A final objective was to use these compounds, if they could be shown to be specific 5-HT M receptor antagonists, in order to test the hypothesis of Wood and Mayer (1979b) that 5-HT is a mediator of slow EPSPs in type II/AH neurons of the myenteric plexus. The experimental plan, therefore, was designed (7) to provide a further test of the proposal that the high affinity 3H-5-HT binding sites in the gut are M 5-HT receptors and (2) to gain additional insight into the physiological role of 5-HT as a neurotransmitter in the ENS.
5-MEOT produced no effect on membrane potential when applied to the surface of myenteric neurons by pressure microejection. It neither mimicked nor antagonized the action of 5-HT. A minority of cells were depolarized when 5-MEOT was superfused over the tissue in high concentration. This action of superfused 5-MEOT, however, was quite different from the actions of 5-HT. It differed from the prolonged slow effect of 5-HT (which could be elicited either by microejection or by superfusion) because the 5-MEOT-induced depolarization was accompanied by a fall in input resistance, whereas the slow depolarization induced by 5-HT was accompanied by a rise. Moreover, 5-HT never produced a decline in input resistance when applied by superfusion. In addition, the postsynaptic depolarization that 5-HT induces when applied by microejection that is associated with a fall in input resistance, in contrast to the action of superfused 5-MEOT, is a fast, rapidly accommodating, response. Finally, desensitization of preparations to 5-HT blocks this fast response to 5-HT, but superfusion with high concentrations of 5-MEOT does not. 5-MEOT, therefore, usually does not affect myenteric neurons which respond to 5-HT. When it does have an action on these cells, its effect is not like that of 5-HT and, thus, the action of 5-MEOT seems unlikely to be mediated by 5-HT receptors. It seems probable, therefore, that, as first concluded by Gyermek (1966) , 5-MEOT is not an agonist at 5-HT M receptors. These observations, however, may provide some insight into apparent discrepancies concerning this drug that have appeared in the literature. Fozard and Mobarok Ali (1978) reported that 5-MEOT did not act on M receptors for 5-HT in the heart but did cause a neurally mediated contraction of the guinea pig ileum. Since a specific 5-HT M receptor antagonist was not available at the time they did their study, Fozard and Mobarok Ali (1978) concluded that 5-MEOT contracted the ileum by acting on 5-HT receptors. However, it seems possible, from the current study, that 5-MEOT may depolarize some myenteric neurons leading to the release of ACh and contraction of the ileum through a mechanism independent of an action on 5-HT receptors. It is thus advantageous to study the effects of compounds nearby of 5-HTP-DP. Constant depolarizing current pulses were Injected through the recording micropipette into a type II/AH neuron. In the absence of drugs a single action potential is evoked at the onset of the injected current pulse, but the cell does not spike repeatedly.
A, MIcroelection of 5-HT (1 mM, 999 msec; arrow) first induces a fast depolarization that is associated with a burst of action potentials. This change is followed by an afterhyperpolarization (during which input resistance is low) that, in turn, is succeeded by a slow, very longlasting depolarizing response (12 mV, 105 set). During the depolarizing response depolarizing current injection evokes multiple action potentials. B, Pressure microejection of 20 drops of 5HTP-DP (10 mM, 999 msec; hor;zonta/ arrow) blocks all phases of the response to one drop of 5-HT (arrow). C, After the dipeptide is washed out, the slow depolarizing response to 5-HT returns (14 mV, 125 set). The resting membrane potential was -67 mV.
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5-HTP-DP(20droPS) , The resting membrane potential was about -55 mV. In this preparation the mean amplitude of the 5-HT-induced slow depolarization was 5.1 f 0.4 mV and the duration was 31.9 f 1.8 sec. After 20 drops of 5-HTP-DP, the mean amplitude was 1.7 f 0.9 mV and the duration was 15.0 + 7.6 set (p < 0.01; 23 df). After 30 drops of 5-HTP-DP no response was elicited by 5-HT in two of three trials; the maximum remaining depolarization was 1.5 mV for 15 set duration.
5-HTP-DP--~llllr.JdII B I , AA Figure 9 . Effect of 5-HTP-DP on the response of a type II/AH neuron to microejection of substance P. The cell was injected with constant depolarizing current pulses through the recording micropipette. A, Substance P (0.6 mM): two pulses (each 900 msec; arrowheads) induce a slow, prolonged depolarization during which the afterhyperpolarization IS reduced and the cell is hyperexcitable.
B, Superfusion with 20 PM 5-HTP-DP fails to block the response to substance P. C, After the dipeptide is 4sec washed out, the response to sibstance P remains as vigorous as before. The resting membrane potential was -67 mV.
on myenteric neurons themselves. Indirect conclusions based on contraction of ileal smooth muscle may be misleading, and discrepancies between data obtained with whole ileum and results obtained with intracellular recordings from individual myenteric neurons may reasonably be expected. In any case, the observations made in the current investigation of the effects of 5-MEOT on individual myenteric neurons are consistent with the observation that 5-MEOT does not antagonize the high affinity enteric binding of 3H-5-HT and, thus, support the notion that enteric high affinity 3H-5-HT binding sites are 5-HT receptors. The dipeptides of 5hydroxytryptophan were found to be antagonists of the enteric neural actions of 5-HT. The slow depolarization associated with an increase in input resistance induced by 5-HT was readily blocked by 5-HTP-DP, but the fast depolarization accompanied by a fall in input resistance was blocked less frequently. It is possible that the two actions of 5-HT, often seen sequentially in the 1 Omsec F/gure 77. Antagonism of a fast EPSP by hexamethonlum. Fast EPSPs were evoked by fiber tract stimulation at 0.5 Hz. The upper tracing shows two superimposed responses. After addition of hexamethonium (0.1 mu), the response was abolished (lower tracing). This sensitivity to hexamethonium helps to confirm the Identity of the nicotinic fast EPSP. The resting membrane potential was -56 mV. same neurons, are mediated by different receptors or a different subtype of the same receptor; however, relatively high concentrations of the dipeptides were necessary to block either effect of 5 HT. When applied by superfusion, a concentration of 1 to 10 pM 5-HTP-DP was required to antagonize a single threshold pulse of 5 HT (1 mu) ejected from a micropipette. Conceivably, a higher concentration of 5HTP-DP than was achieved in our experiments might have more consistently blocked the fast depolarization induced by 5-HT. The effect of the dipeptides did appear to be concentration dependent; antagonism of the action of 5-HT by 5-HTP-DP could be overcome by applying more 5HT, and the block was reversible by washing. In addition to these postsynaptic actions of 5-HT, the presynaptic action of 5HT to reduce the amplitude of the fast EPSP in type l/S cells (North et al., 1980) was also antagonized by 5-HTP-DP. The dipeptides of 5-hydroxyttyptophan, therefore, were antagonists of the neural actions of 5-HT. Their effectiveness in this regard is consistent with their potency in inhibiting the binding of 3H-5-HT. 5-HT is approximately 30 times as potent as 5-HTP-DP and 90 times as potent as N-hex-5-HTP-DP. This disparity in efficacy probably explains why IO to 30 drops of pressure microejected 5-HTP-DP (10 mM) are needed to block the action on myenteric neurons of 1 drop of pressure microejected 5-HT (1 mM).
In contrast to its ability to antagonize effects of 5-HT, 5-HTP-DP did not mimic any of the actions of 5-HT when applied to 5-HTsensitive neurons by microejection, even when given at 300 times the effective amount of 5-HT. 5-HTP-DP, therefore, seems to be only a 5-HT antagonist and seems to have no agonist properties.
Despite the high concentrations of 5-HTP-DP needed to antagonize the effects of 5-HT, the compound appeared at these concentrations to be a relatively specific 5-HT antagonist. 5-HTP-DP did not antagonize the rather similar effects to those of 5-HT on type II/AH neurons of substance P or the muscarinic action of ACh. Moreover, 5-HTP-DP did not affect the amplitude of fast EPSPs in type I/S neurons. The compound, therefore, does not act at substance P, nicotinic, or muscarinic receptors and has not been demonstrated to presynaptically inhibit transmitter release.
The slow EPSP evoked in type II/AH neurons by repetitive stimulation of fiber tracts in interganglionic connectives was reversibly antagonized by 5-HTP-DP and N-hexd-HTP-DP. Since 5-HTP-DP did not block the actions on these cells of substance P or ACh, it is unlikely that its action in antagonizing the slow EPSP can be ascribed to blocking the effect of either of these substances. Moreover, there is no evidence to suggest that 5-HTP-DP interferes with transmitter release or has a local anesthetic action; therefore, in view of its ability to block the neural actions of 5-HT, it can be concluded that the ability of 5-HTP-DP to antagonize the slow EPSP supports the hypothesis that 5-HT is a mediator of this response. Wood and Mayer (1979b) first proposed that the slow EPSP is mediated by 5-HT because 5-HT mimicked the slow EPSP and the slow EPSP was blocked by 5-HT desensitization and by the 5-HT antagonist, methysergide. It soon became apparent that other substances including substance P (Katayama et al., 1979) and ACh (Morita et al., 1982) could also mimic properties of slow synaptic potentials in myenteric neurons. Furthermore, 5-HT has presynaptic effects (North et al., 1980) , and it is thus possible that the procedure used to induce 5-HT desensitization prevents the manifestation of a slow EPSP, not by desensitizing postsynaptic 5-HT receptors, but by inhibiting the release of the authentic transmitter. Methysergide, too, is not a specific 5-HT antagonist at M receptors (Drakontides and Gershon, 1968; Costa and Furness, 1979a, b) . Methysergide may also reduce the amplitude of the fast EPSP (North et all, 1980; Wood, 1983) and, like 5-HT desensitization, could conceivably be acting presynaptically. Moreover, slow EPSPs can also be antagonized by chymotrypsin, a result interpreted to favor mediation of the response by substance P or another peptide (Morita et al., 1980; Johnson et al., 1981) .
More recently, Bornstein et al. (1984) have studied the effects of interruption of the long fiber pathways of the myenteric plexus on slow EPSPs evoked by focal intraganglionic stimulation. Enteric serotonergic neurons are quite long and project great distances down the gut before they appear to give off terminals (Costa et al., 1981; Furness and Costa, 1982) . In contrast, enteric substance P neurons are very short and project extensively within a single ganglion (Costa et al., 1982) . Interruption of long pathways, therefore, produces segments of gut that are depleted of 5-HT but which contain substance P (Bornstein et al., 1984) . These segments do contain cells that manifest a slow EPSP when that response is elicited by focal intraganglionic stimulation; however, a greater number of shocks must be delivered to evoke a slow EPSP after the It should be noted that there are significant differences between investigators in the means employed to evoke slow EPSPs. One method is to utilize stimulation of fiber tracts in interganglionic connectives (Wood and Mayer, 1979a) ; the other is to use focal intraganglionic stimulation (Johnson et al., 1980a) . Because enteric serotonergic neurons are long and substance P neurons are short (Costa et al., 1981 (Costa et al., , 1982 Furness and Costa, 1982) stimulation of interganglionic connectives would be expected to activate relatively more serotonergic axons than those containing substance P. However, stimulation of discrete foci within a ganglion would be expected to be more likely to activate substance P-containing neurites which ramify profusely within a ganglion than would the serotonergic axons which are much less numerous and tend to be dispersed within ganglia. These differences in stimulation may account for apparently discrepant results concerning slow synaptic potentials reported by different investigators. For example, those groups that have used focal intraganglionic stimulation have found slow EPSPs in both type I/S and type II/AH cells (Johnson et al., 1980a; North and Tokimasa, 1982; Bornstein et al., 1984) . In addition, focal intraganglionic stimulation can evoke muscarinic slow EPSPs in type I/S cells with single shock stimuli (North and Tokimasa, 1982) . In contrast, when intergangiionic connectives are stimulated, slow EPSPs can be evoked only in type II/AH neurons (Wood and Mayer, 1979a; Grafe et al., 1980; Wood, 1981 Wood, , 1983 Erde et al., 1984 ) the slow EPSPs are entirely resistant to muscarinic blockade (Wood and Mayer, 1979b) , and repetitive stimulation is required to evoke the response (Wood and Mayer, 1979a) . It seems likely, therefore, that focal intraganglionic stimulation and stimulation of interganglionic connectives activate different inputs to myenteric ganglion cells. It is thus possible that similar slow synaptic responses may be evoked by different inputs utilizing different neurotransmitters. Conceivably, ACh (at least in type I/S cells), substance P, and 5HT all may be mediators of this type of response. long pathways have been eliminated (Bornstein et al., 1984) . These
In the current investigation, the hypothesis of Wood and Mayer results indicate that 5-HT is not the only mediator of slow EPSPs (1979b) that 5-HT is a mediator of slow EPSPs was tested. The evoked by focal intraganglionic stimulation in the myenteric plexus because a slow EPSP can be obtained in the absence of 5HT. Conversely, the greater difficulty encountered in evoking the response when 5HT is depleted suggests that it may contribute even to the response evoked by focal intraganglionic stimulation. method (fiber tract stimulation) of evoking a slow EPSP that was used was, therefore, chosen to be similar to that of Wood and Mayer (1979b) . Moreover, this method also seemed most reasonable because it had, as mentioned above, the best chance of activating the serotonergic inputs to myenteric ganglia. Since we found that the specific 5-HT M receptor antagonist, 5-HTP-DP, was always effective in inhibiting the slow EPSPs evoked by fiber tract stimulation, it seems likely that the serotonergic innervation is probably responsible for mediating many, if not all, of these responses. These observations correlate extremely well with those of Erde et al. (1984) who radioautographically identified the serotonergic inputs to physiologically characterized myenteric neurons. Slow EPSPs in that study were also evoked by stimulation of interganglionic fiber tracts. Slow EPSPs were found only in type II/AH neurons, and these were marked for later electron microscopic study by injection of horseradish peroxidase. Subsequently, the tissues were incubated with 3H-5-HT under conditions in which 3H-5-HT was taken up only into serotonergic axons. Examination of serial electron microscopic radioautographs revealed that every cell that demonstrated a slow EPSP received serotonergic synapses but that such synapses were rare on neurons that did not show a slow EPSP. Both the study of Erde et al. (1984) and the current investigation are compatible with the view that fiber tract stimulation preferentially evokes slow EPSPs in type II/AH neurons by activating serotonergic axons; all such effects are blocked by antagonists (5-HTP-DP and N-hex5HTP-DP) of the neural actions of 5-HT, and serotonergic synapses are actually found on all cells that show the response. The experiments of Bornstein et al. (1984) in which long fiber tracts were cut surgically did not test the role of 5-HT in mediating slow EPSPs evoked by stimulation of long fiber tracts in interganglionic connectives. Bornstein et al. (1984) used focal intraganglionic stimulation and stimulated the short projections between the lesion and the cell they recorded from. Although their results do, as noted earlier, clearly establish that 5-HT cannot be the only transmitter mediating a slow EPSP, it seems reasonable to conclude that 5-HT is one such mediator, probably of long tract neurons. Fiber tract stimulation evokes other effects besides slow EPSPs in myenteric neurons. There is also, for example, a slow inhibitory postsynaptic potential (Fig. 17 in Johnson et al., 1980a ) that is not antagonized by 5-HTP-DP or desensitization to 5-HT. These other effects are probably not mediated by 5-HT.
In conclusion, the current experiments support the hypothesis that enteric high affinity 3H-5-HT binding sites are 5-HT M receptors. They also support the hypothesis that 5-HT is a neurotransmitter that mediates slow EPSPs in type II/AH neurons evoked by activation of fibers in interganglionic connectives of the myenteric plexus.
